MX2018010283A - Metodo para producir factor de crecimiento de hepatocitos (hgf) activo. - Google Patents

Metodo para producir factor de crecimiento de hepatocitos (hgf) activo.

Info

Publication number
MX2018010283A
MX2018010283A MX2018010283A MX2018010283A MX2018010283A MX 2018010283 A MX2018010283 A MX 2018010283A MX 2018010283 A MX2018010283 A MX 2018010283A MX 2018010283 A MX2018010283 A MX 2018010283A MX 2018010283 A MX2018010283 A MX 2018010283A
Authority
MX
Mexico
Prior art keywords
hgfa
growth factor
activated
hepatocyte growth
hgf
Prior art date
Application number
MX2018010283A
Other languages
English (en)
Inventor
Shimizu Masashi
Sato Toshitaka
Arita Yoshihisa
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MX2018010283A publication Critical patent/MX2018010283A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21034—Plasma kallikrein (3.4.21.34)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Abstract

La presente invención proporciona un método para producir activador de factor de crecimiento de hepatocitos activo (HGFA) y factor de crecimiento de hepatocitos activo (HGF) sin usar suero animal. La presente invención se refiere a un método para producir HGFA activo sin usar suero animal. El método se caracteriza porque comprende una etapa de obtener un sobrenadante del cultivo que comprende pro-HGFA, cultivando células de mamífero que expresan activador de factor de crecimiento de hepatocitos inactivo (pro-HGFA) en un medio sin suero, y una etapa de ajustar a débilmente ácido el sobrenadante del cultivo que comprende pro-HGFA obtenido en la etapa anterior para convertir pro-HGFA en HGFA activo. La presente invención se refiere también a un método para producir HGF activo con HGFA producido por el método.
MX2018010283A 2016-03-17 2017-03-15 Metodo para producir factor de crecimiento de hepatocitos (hgf) activo. MX2018010283A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016054128 2016-03-17
PCT/JP2017/010355 WO2017159722A1 (ja) 2016-03-17 2017-03-15 活性型肝細胞増殖因子（ｈｇｆ）の製造方法

Publications (1)

Publication Number Publication Date
MX2018010283A true MX2018010283A (es) 2019-01-31

Family

ID=59850449

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018010283A MX2018010283A (es) 2016-03-17 2017-03-15 Metodo para producir factor de crecimiento de hepatocitos (hgf) activo.

Country Status (16)

Country Link
US (2) US11548926B2 (es)
EP (1) EP3431590B1 (es)
JP (1) JP6861201B2 (es)
KR (1) KR102275262B1 (es)
CN (1) CN109196099B (es)
AU (1) AU2017232582B2 (es)
CA (1) CA3014567C (es)
DK (1) DK3431590T3 (es)
ES (1) ES2894477T3 (es)
HU (1) HUE055414T2 (es)
IL (1) IL261066B (es)
LT (1) LT3431590T (es)
MX (1) MX2018010283A (es)
RU (1) RU2747977C2 (es)
SG (1) SG11201806843UA (es)
WO (1) WO2017159722A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11548926B2 (en) 2016-03-17 2023-01-10 Eisai R&D Management Co., Ltd. Method for producing an active hepatocyte growth factor (HGF)
CN110606883A (zh) * 2019-07-25 2019-12-24 广州凌腾生物医药有限公司 肝细胞生长因子的制备方法
CN110607304A (zh) * 2019-07-25 2019-12-24 广州凌腾生物医药有限公司 肝细胞生长因子的重组表达方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564486B2 (ja) 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
NZ232813A (en) 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
JP2706704B2 (ja) 1989-06-05 1998-01-28 敏一 中村 組換ヒト肝実質細胞増殖因子
JP3036782B2 (ja) 1990-04-03 2000-04-24 三菱化学株式会社 ヒト肝実質細胞増殖因子の生産方法および該因子を産生する形質転換体
JP2577091B2 (ja) 1989-08-11 1997-01-29 三菱化学株式会社 肝実質細胞増殖因子及びそれをコードする遺伝子
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JP3072628B2 (ja) 1990-11-19 2000-07-31 敏一 中村 ヒト肝実質細胞増殖因子をコードする染色体ｄｎａ
JP3213985B2 (ja) * 1991-10-18 2001-10-02 三菱化学株式会社 新規なタンパク質
CA2102463A1 (en) * 1992-11-05 1994-05-06 Mitsubishi Chemical Corporation Protein and gene encoding said protein
JP3232714B2 (ja) * 1992-11-20 2001-11-26 三菱化学株式会社 新規なタンパク質およびそれをコードする遺伝子
JP3698721B2 (ja) 1993-02-23 2005-09-21 ジェネンテク・インコーポレイテッド 有機溶媒を用いて処理したポリペプチドの賦形剤安定化
JP2577091Y2 (ja) 1993-06-23 1998-07-23 賢一 片山 分流装置の合成樹脂製サドル
JP3680114B2 (ja) * 1993-09-17 2005-08-10 敏一 中村 脳神経障害治療剤
JP2747979B2 (ja) 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
JP3927248B2 (ja) 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
JP2859577B2 (ja) 1996-03-27 1999-02-17 三菱化学株式会社 肝実質細胞増殖因子
JP4463885B2 (ja) 1996-12-05 2010-05-19 敏一 中村 劇症肝炎疾患治療剤
JP2980888B2 (ja) 1998-07-09 1999-11-22 三菱化学株式会社 肝実質細胞増殖因子をコードする遺伝子
ATE359809T1 (de) 1999-05-31 2007-05-15 Mitsubishi Chem Corp Gefriergetrocknete hgf-präparationen
JP3072628U (ja) 2000-02-17 2000-10-24 輝夫 尾形 ステンドグラス製文字入り記念楯
JP4090236B2 (ja) * 2000-12-05 2008-05-28 三菱化学株式会社 活性型肝細胞増殖因子アクティベーターに対する特異的抗体とその使用法
US7045602B2 (en) * 2000-12-05 2006-05-16 Mitsubishi Chemical Corporation Specific antibody directed to active hepatocyte growth factor activator and method for using the same
DE10204792A1 (de) 2002-02-06 2003-08-14 Merck Patent Gmbh Lyophilisierte Zubereitung enthaltend Immuncytokine
US7432044B2 (en) 2004-07-26 2008-10-07 Genentech, Inc. Methods and compositions for modulating hepatocyte growth factor activation
US7741096B2 (en) * 2004-12-10 2010-06-22 Genentech, Inc. Crystal structure of hepatocyte growth factor activator complexed with Kunitz domain inhibitor
CA2628928A1 (en) * 2005-11-10 2007-05-24 Receptor Biologix, Inc. Hepatocyte growth factor intron fusion proteins
JP5093783B2 (ja) 2006-04-20 2012-12-12 クリングルファーマ株式会社 Ｈｇｆ前駆体蛋白質改変体及びその活性型蛋白質
CA2673260A1 (en) 2006-12-20 2008-07-03 Bayer Healthcare Llc Factor vii and viia compositions
WO2008102452A1 (ja) 2007-02-22 2008-08-28 Kringle Pharma Inc. Ｈｇｆ製剤
CN102271707B (zh) 2008-10-29 2015-04-08 阿布林克斯公司 单域抗原结合性分子的制剂
CN101649320B (zh) * 2009-09-15 2011-06-15 上海交通大学医学院附属仁济医院 重组人源hgf激活因子及其应用
BR112012009245A2 (pt) * 2009-10-19 2019-09-24 Genentech Inc ''anticorpo,polinucleotídeo,celula hospedeira,método para fabricar um anticorpo,imunoconjugado,formulação farmacêutica e uso do anticorpo''
WO2011102845A1 (en) 2010-02-18 2011-08-25 Transtech Pharma, Inc. Rage fusion protein compositions and methods of use
JP2012051822A (ja) 2010-08-31 2012-03-15 Institute Of Physical & Chemical Research 肺癌診断用ポリペプチド、肺癌の検出方法、および治療効果の評価方法
US9272018B2 (en) 2011-04-18 2016-03-01 Kyoto University Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof
WO2013018851A1 (ja) 2011-08-02 2013-02-07 独立行政法人国立がん研究センター 誘導肝幹細胞から肝分化誘導する方法及び誘導肝前駆細胞
AU2013201422B2 (en) * 2012-01-23 2015-04-09 Ablynx Nv Sequences directed against hepatocyte growth factor (HFG) and polypeptides comprising the same for the treatment of cancers and/or tumors
EP2908862B1 (en) 2012-10-20 2018-03-07 Board Of Regents, The University Of Texas System Cancer cell trap
RU2506946C1 (ru) 2012-11-28 2014-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Технология лиофилизации обогащенной тромбоцитами плазмы с сохранением жизнеспособности факторов tgf pdgf vegf
ES2887079T3 (es) 2014-04-28 2021-12-21 Eisai R&D Man Co Ltd Preparación de HGF liofilizada
US11548926B2 (en) 2016-03-17 2023-01-10 Eisai R&D Management Co., Ltd. Method for producing an active hepatocyte growth factor (HGF)
US20200341014A1 (en) 2016-03-18 2020-10-29 Eisai R&D Management Co., Ltd. PD Marker of Hepatocyte Growth Factor (HGF)
CN208371461U (zh) 2017-08-21 2019-01-15 潍坊鸿旺工贸有限公司 一种晾衣架用连接构件及晾衣架

Also Published As

Publication number Publication date
AU2017232582A1 (en) 2018-08-30
US20190062390A1 (en) 2019-02-28
IL261066B (en) 2021-08-31
SG11201806843UA (en) 2018-09-27
US20220267393A1 (en) 2022-08-25
EP3431590A1 (en) 2019-01-23
ES2894477T3 (es) 2022-02-14
RU2018130530A3 (es) 2020-08-13
KR20180127322A (ko) 2018-11-28
RU2747977C2 (ru) 2021-05-18
AU2017232582B2 (en) 2022-07-14
KR102275262B1 (ko) 2021-07-12
JPWO2017159722A1 (ja) 2019-01-24
IL261066A (en) 2018-10-31
EP3431590A4 (en) 2019-11-20
DK3431590T3 (da) 2021-10-11
HUE055414T2 (hu) 2021-11-29
EP3431590B1 (en) 2021-07-28
WO2017159722A1 (ja) 2017-09-21
CN109196099B (zh) 2022-01-11
RU2018130530A (ru) 2020-04-17
US11548926B2 (en) 2023-01-10
LT3431590T (lt) 2021-09-10
CA3014567C (en) 2024-02-20
CA3014567A1 (en) 2017-09-21
CN109196099A (zh) 2019-01-11
JP6861201B2 (ja) 2021-04-21

Similar Documents

Publication Publication Date Title
MX2023009109A (es) Una variante de isopropilmalato sintasa novedosa y un procedimiento de produccion de l-leucina usando la misma.
PH12015501837A1 (en) Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recominbinant proteins
MY181513A (en) Cell culture compositions and methods for polypeptide production
BR112018002214A2 (pt) ?métodos para cultivar células e para produzir uma proteína, meios de cultura de células cho e de batelada alimentada e/ou alimentação, e, alimentação de cultura de células cho?
UA92157C2 (ru) Способ продуцирования гормона роста
EP3546570A4 (en) KIT WITH MEDIUM FOR THE CULTURE OF SERUM-FREE IMMUNELL CELLS, METHOD FOR THE CULTURE OF IMMUNAL CELLS BY USE OF THE KIT, SERUM-FREE IMMUNE CELL CULTURE RECEIVED BY THE KIT OR CULTURE METHOD AND COSMETIC COMPOSITION
MX2019002252A (es) Metodo para producir una proteina de fusion de anticuerpo.
MY163081A (en) Animal cell culturing method
WO2009028338A1 (ja) 新規オキシダーゼ遺伝子、および該遺伝子を利用する３－インドールピルビン酸の製造方法
MX2018010283A (es) Metodo para producir factor de crecimiento de hepatocitos (hgf) activo.
MX2022010521A (es) Metodo para producir linfocitos citoliticos naturales a partir de celulas madre pluripotentes.
PH12014502870A1 (en) Method of producing recombinant iduronate-2-sulfatase
WO2017051347A3 (en) Cells and method of cell culture
WO2018203947A3 (en) MODIFIED BIOSYNTHESIS PATHWAYS FOR FERMENTATION TYRAMINE PRODUCTION
EA201591547A1 (ru) Система и способ контролируемого получения метаболитов путем микробиологической ферментации
WO2011129462A3 (en) A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME
EP3889252A4 (en) CELL CULTURE MICROSCARRIER, METHOD FOR PRODUCING IT, AND CELL CULTURE METHOD USING THE SAME
MX2016013223A (es) Formulacion en polvo de medio de compuesto y metodo de preparacion de medio liquido para cultivo celular.
EP3848455A4 (en) Medium for direct differentiation of pluripotent stem cell-derived mesenchymal stem cell, method for preparing mesenchymal stem cell by using same, and mesenchymal stem cell prepared thereby
EP4039796A4 (en) METHOD FOR PRODUCING COMPOSITION FOR CELL CULTURE, COMPOSITION FOR CELL CULTURE OBTAINED THEREBY, AND CELL CULTURE METHOD USING SAME
MX2021001528A (es) Metodo para la produccion de celulas positivas para cd3.
MY197429A (en) Afucosylated antibodies and manufacture thereof
WO2018183848A8 (en) Media for microorganism culture and related compositions and methods
WO2008111430A1 (ja) γδＴ細胞集団の製造方法
EP4235175A3 (en) Methods for culturing human keratinocytes